BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 237741)

  • 1. Clinical assessment of lorazepam in anxiety: a double-blind study.
    Olgiati SG
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
    Hart WL; Parmley LF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Lorazepam in the treatment of neurosis--an uncontrolled clinical study.
    Ananth V; Beszterczy A; Geagea C
    Psychopharmacol Bull; 1976 Jan; 12(1):19-21. PubMed ID: 1825
    [No Abstract]   [Full Text] [Related]  

  • 6. Lorazepam in the management of anxiety associated with chronic gastrointestinal disease: a double-blind study.
    Kasich AM
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):292-306. PubMed ID: 5247
    [No Abstract]   [Full Text] [Related]  

  • 7. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
    Stokes DK
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical assessment of lorazepam in the treatment of anxiety associated with gastrointestinal symptomatology.
    Berkowitz JM
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):46-52. PubMed ID: 30768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
    McCurdy L; Schatzberg AF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):30-4. PubMed ID: 30765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
    Bobon DP; Fanielle J; Mormont C; Breulet M; Bobon J
    Acta Psychiatr Belg; 1978; 78(4):619-34. PubMed ID: 31063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiclinic double-blind trial of the anxiolytic properties of lorazepam in psychiatric outpatient practice [proceedings].
    Lipman R; Vanov SK; Richards DJ
    Psychopharmacol Bull; 1977 Apr; 13(2):17-9. PubMed ID: 16308
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind cross-over clinical comparison of two 2'-chloro benzodiazepines: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (chlordesmethyldiazepam) versus 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in neurotic anxiety.
    Andreoli V; Maffei F; Montanaro N; Morandini G
    Arzneimittelforschung; 1977 Feb; 27(2):436-9. PubMed ID: 16622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and withdrawal of two potent benzodiazepines: bromazepam and lorazepam.
    Fontaine R; Annable L; Beaudry P; Mercier P; Chouinard G
    Psychopharmacol Bull; 1985; 21(1):91-2. PubMed ID: 2858908
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the safety and therapeutic effects of lorazepam on long-term use.
    Siassi I; Thomas M; Vanov SK
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):163-71. PubMed ID: 240649
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical comparison between alprazolam and lorazepam. A polycentric study in double blind].
    Botte L; Bienfait J; Dethier J; Even P; Evrard JL; Fraipont J; Goffin L; Willemse P
    Acta Psychiatr Belg; 1981; 81(6):595-608. PubMed ID: 6125089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Double-blind trial treatment of anxiety with b 5833].
    Cloquette R
    Acta Psychiatr Belg; 1974 May; 74(3):317-26. PubMed ID: 4156149
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
    Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
    Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.